Andrew Schutte
Chief Executive Officer en REPLICEL LIFE SCIENCES INC. .
Fortuna: 779 004 $ al 31/03/2024
Perfil
Andrew Schutte is currently the President, Chief Executive Officer & Director at RepliCel Life Sciences, Inc. He is also the President at Nolan Olbohrung, LLC and Valence Oil LLC.
Previously, he served as the Chief Technology Officer at MainPointe Pharmaceuticals LLC from 2016 to 2022.
Prior to that, he worked as a VBA Programmer at Gerimed, Inc. from 2012 to 2016.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REPLICEL LIFE SCIENCES INC.
26.77% | 16/08/2023 | 17 401 616 ( 26.77% ) | 765 671 $ | 31/03/2024 |
| 16/08/2023 | 303 030 ( 27.82% ) | 13 333 $ | 31/03/2024 |
Cargos activos de Andrew Schutte
| Empresas | Cargo | Inicio |
|---|---|---|
| REPLICEL LIFE SCIENCES INC. | Chief Executive Officer | 28/11/2022 |
| Nolan Olbohrung, LLC | President | - |
| Valence Oil LLC | President | - |
Antiguos cargos conocidos de Andrew Schutte.
| Empresas | Cargo | Fin |
|---|---|---|
MainPointe Pharmaceuticals LLC
 MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Chief Tech/Sci/R&D Officer | 01/06/2022 |
| Gerimed, Inc. | Corporate Officer/Principal | 01/02/2016 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REPLICEL LIFE SCIENCES INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
MainPointe Pharmaceuticals LLC
MainPointe Pharmaceuticals LLC Medical DistributorsDistribution Services MainPointe Pharmaceuticals LLC is a private company based in an undisclosed location, founded by John L. Schutte. The American company specializes in sales and innovative distribution of consumer health differentiated brands and valued supplements that often utilizes unique technologies to improve patient outcomes and enhance consumer wellness. MainPointe Pharmaceuticals has a management team with more than 50 years of industry experience, established relationships, and superior reputations. The company has a unique access to capital and nimble company structure that makes it unique among similar-sized pharmaceutical companies. Since its launch in 2017, MainPointe Pharmaceuticals has brought nine products to market and is aggressively pursuing new products to bring to market. The company specializes in selling and distributing over-the-counter drugs and supplements. | Distribution Services |
| Gerimed, Inc. | |
| Nolan Olbohrung, LLC | |
| Valence Oil LLC |
- Bolsa de valores
- Insiders
- Andrew Schutte
